Skin hyperproliferation and susceptibility to chemical carcinogenesis in transgenic mice expressing E6 and E7 of human papillomavirus type 38

Journal of Virology

Volumn 79, Issue 23, 2005, Pages 14899-14908

  Dong, Wen ^a   Kloz, Ulrich ^b   Accardi, Rosita ^a   Caldeira, Sandra ^b   Tong, Wei Min ^a   Wang, Zhao Qi ^a   Jansen, Lars ^c   Durst, Matthias ^c   Sylla, Bakary S ^a   Gissmann, Lutz ^b   Tommasino, Massimo ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYTOKERATIN 10; KI 67 ANTIGEN; PROTEIN E6; PROTEIN E7;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SUSCEPTIBILITY; CELL CYCLE; CELL HYPERPLASIA; CELL IMMORTALIZATION; CELL PROLIFERATION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DYSPLASIA; EPIDERMIS; HISTOPATHOLOGY; HUMAN PAPILLOMAVIRUS TYPE 38; IN VIVO STUDY; KERATINOCYTE; KERATOACANTHOMA; MITOSIS INHIBITION; MOUSE; NONHUMAN; PAPILLOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SKIN CARCINOGENESIS; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; TRANSGENIC MOUSE; VIRUS GENE; WART VIRUS;

ANIMALS; CARCINOGENICITY TESTS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; EPIDERMIS; KERATINOCYTES; MICE; MICE, TRANSGENIC; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS E7 PROTEINS;

ANIMALIA; BOVINAE; HUMAN PAPILLOMAVIRUS TYPE 38; HUMAN PAPILLOMAVIRUS TYPES; MUS MUSCULUS;

EID: 27744590047     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.23.14899-14908.2005     Document Type: Article

References (36)

1. Auewarakul, P., L. Gissmann, and A. Cidarregui. 1994. Targeted expression of the E6 and E7 oncogenes of human papillomavirus type 16 in the epidermis of transgenic mice elicits generalized epidermal hyperplasia involving autocrine factors. Mol. Cell. Biol. 14:8250-8258.
2. Blessing, M., J. L. Jorcano, and W. W. Franke. 1989. Enhancer elements directing cell-type-specific expression of cytokeratin genes and changes of the epithelial cytoskeleton by transfections of hybrid cytokeratin genes. EMBO J. 8:117-126.
3. Bowden, G. T. 2004. Prevention of non-melanoma skin cancer by targeting ultraviolet-B-light signalling. Nat. Rev. Cancer 4:23-35.
4. Boyle, J., R. M. MacKie, J. D. Briggs, B. J. Junor, and T. C. Aitchison. 1984. Cancer warts, and sunshine in renal transplant patients. A case-control study. Lancet i:702-705.
5. Caldeira, S., R. Filotico, R Accardi, I. Zehbe, S. Franceschi, and M. Tommasino. 2004. p53 mutations are common in human papillomavirus type 38-positive non-melanoma skin cancers. Cancer Lett. 209:119-124.
6. Caldeira, S., I. Zehbe, R. Accardi, I. Malanchi, W. Dong, M. Giarre, E.-M. deVilliers, R. Filotico, P. Boukamp, and M. Tommasino. 2003. The E6 and E7 proteins of cutaneous human papillomavirus type 38 display transforming properties. J. Virol. 77:2195-2206.
7. de Villiers, E. M., C. Fauquet, T. R. Broker, H. U. Bernard, and H. zur Hausen. 2004. Classification of papillomaviruses. Virology 324:17-27.
8. Durst, M., D. Glitz, A. Schneider, and H. zur Hausen. 1992, Human papillomavirus type 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: analysis by in situ hybridization. Virology 189:132-140.
9. Eckert, R. L., J. F. Crish, S. Balasubramanian, and E. A. Rorke. 2000. Transgenic animal models of human papillomavirus-dependent disease. Int. J. Oncol. 16:853-870.
10. Griep, A. E., and P. F. Lambert. 1994. Role of papillomavirus oncogenes in human cervical cancer: transgenic animal studies. Proc. Soc. Exp. Biol. Med. 206:24-34.
11. Hartevelt, M. M., J. N. Bavinck, A. M. Kootte, B. J. Vermeer, and J. P. Vandenbroucke. 1990. Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation 49:506-509.
12. Hellrich, I., M. Chen, R. Schmidt, G. Furstenberger, A. Kopp-Schneider, D. Trick, H. J. Grone, H. Zur Hausen, and F. Rosl. 2004. Increased incidence of squamous cell carcinomas in Mastomys natalensis papillomavirus E6 transgenic mice during two-stage skin carcinogenesis. J. Virol. 78:4797-4805.
13. Iftner, T., S. Bierfelder, Z. Csapo, and H. Pfister. 1988. Involvement of human papillomavirus type 8 genes E6 and E7 in transformation and replication. J. Virol. 62:3655-3661.
14. Jablonska, S., J. Dabrowski, and K. Jakubowicz. 1972. Epidermodysplasia verruciformis as a model in studies on the role of papovaviruses in oncogenesis. Cancer Res. 32:583-589.
15. Jackson, S., C. Harwood, M. Thomas, L. Banks, and A. Storey. 2000. Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev. 14:3065-3073.
16. Kiviat, N. B. 1999. Papillomaviruses in non-melanoma skin cancer: epidemiological aspects. Semin. Cancer Biol. 9:397-403.
17. Kreimer, A. R., G. M. Clifford, P. Boyle, and S. Franceschi. 2005. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol. Biomarkers Prev. 14:467-475.
18. Lambert, P. F., H. Pan, H. C. Pitot, A. Liem, M. Jackson, and A. E. Griep. 1993. Epidermal cancer associated with expression of human papillomavirus type 16 E6 and E7 oncogenes in the skin of transgenic mice. Proc. Natl. Acad. Sci. USA 90:5583-5587.
19. Lee, D. H., and G. P. Pfeifer. 2003. Deamination of 5-methylcytosines within cyclobutane pyrimidine dimers is an important component of UVB mutagenesis. J. Biol. Chem. 278:10314-10321.
20. Majewski, S., S. Jablonska, and G. Orth. 1997. Epidermodysplasia verruciformis. Immunological and nonimmunological surveillance mechanisms: role in tumor progression. Clin. Dermatol. 15:321-334.
21. Malanchi, I., R. Accardi, F. Diehl, A. Smet, E. Androphy, J. Hoheisel, and M. Tommasino. 2004. Human papillomavirus type 16 E6 promotes retinoblastoma protein phosphorylation and cell cycle progression. J. Virol. 78:13769-13778.
22. 1/S transition. Oncogene 21:5665-5672.
23. Mantovani, F., and L. Banks. 2001. The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 20:7874-7887.
24. Munger, K., A. Baldwin, K. M. Edwards, H. Hayakawa, C. L. Nguyen, M. Owens, M. Grace, and K. Huh. 2004. Mechanisms of human papillomavirus-induced oncogenesis. J. Virol. 78:11451-11460.
25. Munger, K., J. R. Basile, S. Duensing, A. Eichten, S. L. Gonzalez, M. Grace, and V. L. Zacny. 2001. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 20:7888-7898.
26. Nguyen, M. L., M. M. Nguyen, D. Lee, A. E. Griep, and P. F. Lambert. 2003. The PDZ ligand domain of the human papillomavirus type 16 E6 protein is required for E6's induction of epithelial hyperplasia in vivo. J. Virol. 77: 6957-6964.
27. Orth, G., S. Jablonska, M. Jarzabek-Chorzelska, S. Obalek, G. Rzesa, M. Favre, and O. Croissant. 1979. Characteristics of the lesions and risk of malignant conversion associated with the type of human papillomavirus involved in epidermodysplasia verruciformis. Cancer Res. 39:1074-1082.
28. Pfister, H. 2003. Chapter 8: human papillomavirus and skin cancer. J. Natl. Cancer Inst. Monogr, 31:52-56.
29. Schaper, I. D., G. P. Marcuzzi, S. J. Weissenborn, H. U. Kasper, V. Dries, N. Smyth, P. Fuchs, and H. Pfister. 2005. Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8. Cancer Res. 65:1394-1400.
30. Song, S., A. Liem, J. A. Miller, and P. F. Lambert. 2000. Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis. Virology 267:141-150.
31. Song, S., H. C. Pitot, and P. F. Lambert. 1999. The human papillomavirus type 16 E6 gene alone is sufficient to induce carcinomas in transgenic animals. J. Virol, 73:5887-5893.
32. Walder, B. K., D. Jeremy, J. A. Charlesworth, G. J. Macdonald, B. A. Pussell, and M. R. Robertson. 1976. The skin and immunosuppression. Australas. J. Dermatol. 17:94-97.
33. Walder, B. K., M. R. Robertson, and D. Jeremy. 1971. Skin cancer and immunosuppression. Lancet ii:1282-1283.
34. Weissenborn, S. J., I. Nindl, K. Purdie, C. Harwood, C. Proby, J. Breuer, S. Majewski, H. Pfister, and U. Wieland. 2005. Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers. J. Investig. Dermatol. 125:93-97.
35. Yamashita, T., K. Segawa, Y. Fujinaga, T. Nishikawa, and K. Fujinaga. 1993. Biological and biochemical activity of E7 genes of the cutaneous human papillomavirus type 5 and 8. Oncogene 8:2433-2441.
36. zur Hausen, H. 2002. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2:342-350.